Compound formula for relieving testis senescence injury by comprehensively correcting cell reactive oxygen species metabolic disorders
A technology of metabolic disorder and cell activity, which is applied in the direction of pharmaceutical formulations, organic active ingredients, medical preparations containing active ingredients, etc., can solve the problems of not considering the role of second messengers, spermatogenesis inhibition, and large side effects, etc., to benefit the product Develop and market, improve the level of expression, increase the effect of the effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Embodiment 1
[0033] Example 1 Evaluation of formulation effectiveness and safety based on high-throughput standardized cell experiments.
[0034] On the basis of previous work, using high-throughput standard cell experiments, the optimal dosage of each component of the formula was screened out to form formula A: melatonin (2mg / d), lipoic acid (200mg / d), nicotinamide riboside (300mg / d).
[0035] Based on the previous work of the present invention, the corresponding ratio concentrations of each component in the formula A were respectively selected (the mass concentration ratio is according to the above order: 1:100:150, when the final concentration of melatonin in the culture solution is 0.1 μmol / L The formula A configured according to the above ratio is 1 U), and the viability and ATP production of vascular endothelial cells were measured by the absorbance method, and the T test analysis was carried out on the basis of the data of 5 independent experiments; with P0.01 is used as the toxic d...
Embodiment 2
[0036] Example 2 Experiment on the elimination effect of ROS free radicals in testicular cells.
[0037] Based on the ratio and final concentration units of formula A in Example 1, the intracellular ROS elimination and damage effects were determined at an optimal concentration of 50 U. First, DCF probe was used to measure the relative concentration of intracellular ROS, and it was found that the A pretreatment group was 51.7% lower than the negative control group; secondly, the cell death rate was measured by propidium iodide staining flow cytometry, and it was found that the formula A pretreatment group had a mortality rate of 0.8 %, the negative control group was 7.9%, and the T test found that the difference was significant after 5 independent experiments. The above data shows that this formula A can reduce the level of intracellular ROS and reduce cell death, so it can effectively protect the cell damage caused by ROS.
Embodiment 3
[0038] Example 3 A randomized double-blind controlled multi-center volunteer experiment of this formula at an optimal concentration.
[0039] From April 2018 to April 2019, in Beijing, Xi'an and Xianyang, a total of 150 male volunteers were selected from each city, with an average age of 41.2 years and a body mass index of 22.3. Volunteers used formula A prepared in Example 1 whose appearance could not be distinguished, and products B and C already on the market for a total of 120 days (formula A was dosed according to Example 1, and products B and C were taken according to the instructions). Volunteer experiments were conducted on the principle of blind control.
[0040] The sperm count, motility, acrosome integrity and sperm ROS concentration of the volunteers were measured respectively, and the above results were normalized to generate a sperm pathological aging damage score. The results show that formula A can finally reduce the pathological aging damage of volunteers' sp...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com